Le Lézard
Classified in: Health, Covid-19 virus
Subjects: CALENDAR OF EVENTS, Conference Calls/ Webcasts

Arbutus to Participate in Two Upcoming Investor Conferences


WARMINSTER, Pa., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the Arbutus management team will participate in and host one-on-one meetings at the following two upcoming investor conferences:

H.C. Wainwright 25th Annual Global Investment Conference: Formal Presentation on September 12, 2023 at 3:30 pm ET

Baird's 2023 Global Healthcare Conference: Fireside Chat on September 13, 2023 at 7:55 am ET

To access the live webcast of the presentations please visit: https://investor.arbutusbio.com/events-presentations. An archived replay of the webcast will be available on the Arbutus website for a limited time after the event.

About Arbutus

Arbutus Biopharma Corporation (Nasdaq: ABUS) is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases. Our current focus areas include Hepatitis B virus (HBV), SARS-CoV-2, and other coronaviruses. To address HBV, we are developing a RNAi therapeutic, an oral PD-L1 inhibitor, and an oral RNA destabilizer to potentially identify a combination regimen with the aim of providing a functional cure for patients with chronic HBV by suppressing viral replication, reducing surface antigen and reawakening the immune system. We believe our lead compound, AB-729, is the only RNAi therapeutic with evidence of immune re-awakening. AB-729 is currently being evaluated in multiple phase 2 clinical trials. We also have an ongoing drug discovery and development program directed to identifying novel, orally active agents for treating coronaviruses, (including SARS-CoV-2), for which we have nominated a compound and have begun IND-enabling pre-clinical studies. In addition, we are also exploring oncology applications for our internal PD-L1 portfolio. For more information, visit www.arbutusbio.com.

Contact Information

Investors and Media

Lisa M. Caperelli
Vice President, Investor Relations
Phone: 215-206-1822
Email: [email protected]



These press releases may also interest you

at 15:30
Laborie Introduces Solar Compact System and Solar Anorectal Manometry Catheter for Enhanced Gastrointestinal Diagnostics
Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. (Laborie), is proud to introduce the Solar Compact System and Solar Anorectal Manometry Catheter, the first disposable HRAM catheter on the market....

at 15:21
Louisiana Businessman & Philanthropist Gains National Recognition for Fighting Child Abuse Statewide
Louisiana businessman and philanthropist Steve Tujague, founder of the IJN Foundation (In Jesus' Name), is receiving national acclaim for his support and advocacy in the state's fight against child abuse and trafficking, and specifically his...

at 15:15
Northwell Health's Katz Institute for Women's Health partners with Hearst Magazines for Women's Health Health Lab event
A star-studded and powerful room of women's health advocates, experts, and leaders came together at Hearst Tower in New York City on May 15 for the inaugural Women's Health Health Lab in partnership with the Northwell Health's Katz Institute for...

at 15:07
Studies Show Linked Biological Pathways Driving Skin Inflammation
A certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin disease psoriasis, a new study finds. The work could lead to improved therapies for all inflammatory skin diseases, including atopic and...

at 14:48
New Tool Flags Hidden Sexual Struggles in Female Partners of Patients With Prostate Cancer
The partners of patients with prostate cancer grapple with their own quality-of-life issues that impact their sexual well-being, a new study shows. Using the first questionnaire of its kind, the authors uncovered key challenges faced by patients'...

at 14:15
InventHelp Inventor Develops Tracheal Bibb for Patients with Tracheostomy Tubes (BRK-4289)
"I'm a nurse and I thought there should be a way to combine a tracheal tie together with a tracheal sponge or bib," said an inventor, from Tuscaloosa, Ala., "so I invented the TRACHEAL BIBB. My design would secure and protect the tracheal stoma, and...

More news about Health...


News published on and distributed by: